Literature DB >> 7357794

Influence of neuroticism on oral absorption of diazepam.

S Nakano, N Ogawa, Y Kawazu.   

Abstract

The subjects were 24 healthy males, 19 to 21 yr old. Twelve subjects had high neuroticism (HN) levels determined by Maudsley Personality Inventory, and 12 had low neuroticism (LN) levels. Subjects took a single 5-mg dose of diazepam (DZP) after a standardized breakfast. The mean plasma concentration for DZP was significantly higher in HN subjects at 1.5 hr after drug than in LN subjects. No difference was found in the DZP plasma levels of these 2 groups after administering the drug directly into the duodenum through a tube. No clear relationship between plasma DZP concentrations and DZP-induced sedative effects determined by Choice Reaction Time Test (CRTT) was demonstrated in the study. The results suggest that the absorption rate of DZP from the gastrointestinal tract is faster in HN subjects than in LN subjects due to the faster gastric emptying time in HN subjects in our experimental situation, which might have induced mild stress.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7357794     DOI: 10.1038/clpt.1980.49

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  9 in total

1.  Sensation seeking amongst healthy volunteers participating in phase I clinical trials.

Authors:  M Farré; X Lamas; J Camí
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

2.  Pharmacokinetic responses to caffeine in volunteers with higher scores for neuroticism.

Authors:  F P Meyer
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

Review 3.  Anaesthetic premedication: aims, assessment and methods.

Authors:  T H Madej; R T Paasuke
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

4.  The healthy volunteer in clinical pharmacology: personality and motivation.

Authors:  F P Meyer; R Haschke; F W Röhl
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

5.  Personality and theophylline pharmacokinetics.

Authors:  S H Jackson; C A Cooper; T H Turner
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Pharmacokinetics of viloxazine hydrochloride in man.

Authors:  B Vandel; S Vandel; J M Jounet; D Blum
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982 Jan-Mar       Impact factor: 2.441

7.  The effect of level of depression on the use of visual analogue scales by normal volunteers.

Authors:  M Peet; S Ellis; R A Yates
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

8.  Who volunteers for phase I clinical trials? Influences of anxiety, social anxiety and depressive symptoms on self-selection and the reporting of adverse events.

Authors:  Luis Almeida; Todd B Kashdan; Teresa Nunes; Rui Coelho; António Albino-Teixeira; Patrício Soares-da-Silva
Journal:  Eur J Clin Pharmacol       Date:  2008-06       Impact factor: 3.064

9.  Psychological Status of Volunteers in a Phase I Clinical Trial Assessed by Symptom Checklist 90 (SCL-90) and Eysenck Personality Questionnaire (EPQ).

Authors:  Yudong Wei; Haiyan Li; Huali Wang; Shuang Zhang; Yumei Sun
Journal:  Med Sci Monit       Date:  2018-07-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.